Design and Implementation of an Anti–Factor Xa Heparin Monitoring Protocol
Author(s) -
Tanya Williams-Norwood,
Megan Caswell,
Barbara Milner,
Joseph C. Vescera,
Kelly Prymicz,
Amy G. Ciszak,
Carol Ingle,
Christopher Lacey,
Evi X. Stavrou
Publication year - 2020
Publication title -
aacn advanced critical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.285
H-Index - 43
eISSN - 1559-7776
pISSN - 1559-7768
DOI - 10.4037/aacnacc2020132
Subject(s) - partial thromboplastin time , medicine , heparin , protocol (science) , intensive care medicine , surgery , coagulation , alternative medicine , pathology
The VA Northeast Ohio Healthcare System introduced a new nurse-driven anti-factor Xa (anti-Xa) protocol for monitoring unfractionated heparin to replace the previous activated partial thromboplastin time protocol.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom